PsyKey Inc. is vertically integrated in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations, for use in its premium quality functional product lines to help improve and optimize everyday life.

 Psykey is also engaged in the scientific development of patentable technologies pertaining to the composition, bioavailability, and targeted delivery of entheogenic based therapeutics for the fast-evolving psychedelic market.

Patent Development

PsyKey Inc. is currently in the development stages of patentable cutting-edge novel technologies, that will directly support and impact the fast-evolving therapeutic psilocybin market. These technologies are focused on composition, bioavailability, and targeted delivery.

PsyKey intends to submit two patent filings in Q2-Q3 2021, while the development and proof of concept continues on multiple other novel technologies.